top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Long-Term Consequences of Adolescent Drug Use: Evidence from Pre-Clinical and Clinical Models
Long-Term Consequences of Adolescent Drug Use: Evidence from Pre-Clinical and Clinical Models
Autore Mary M. Torregrossa
Pubbl/distr/stampa Frontiers Media SA, 2018
Descrizione fisica 1 electronic resource (201 p.)
Collana Frontiers Research Topics
Soggetto non controllato alcohol
stress
nicotine
cocaine
ketamine
methamphetamine
cannabinoid
prefrontal cortex
juvenile
sex differences
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Long-Term Consequences of Adolescent Drug Use
Record Nr. UNINA-9910346746503321
Mary M. Torregrossa  
Frontiers Media SA, 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Marine Compounds and Cancer 2020
Marine Compounds and Cancer 2020
Autore Honecker Friedemann
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (480 p.)
Soggetto topico Medicine
Soggetto non controllato apoptosis
fucoidan
hepatocellular carcinoma
reactive oxygen species
3-alkylpyridinium polymers
nicotine
nicotinic acetylcholine receptor
non-small cell lung carcinoma
melanoma
sinulariolide
proteomic
mitochondria
caspase cascade
marine fungus
sediment
anthranilic acid
Penicillium paneum
cytotoxicity
dibromotyrosine
mitochondrial dysfunction
oxidative stress
topoisomerase
epigonal organ
bonnethead shark
Jurkat
tumor cell line
hippuristanol
PEL
AP-1
STAT3
Akt
colorectal cancer
marine mollusc
brominated indoles
shrimp
chemoprevention
fatty acids
carotenoids
cancer
nanoparticle
osteosarcoma
lung metastasis
elisidepsin
lipid rafts
hydroxylated lipids
fatty acid 2-hydroxylase
cooperative binding
membrane permeabilization
marine organisms
polysaccharides
anticancer
anticarcinogenic
mechanisms of action
fumigaclavine C
anti-proliferation
mitochondrial pathway
anti-cancer
anti-proliferative
carotenoid
cell cycle arrest
fucoxanthin
azoxymethane
bioactive natural product
isatin
in vivo model
Marthasterias glacialis L.
palmitic acid
ER-stress
CHOP
Antibody Drug Conjugates (ADCs)
marine antitumor agents
clinical trials
approved antitumor agents
AD0157
angiogenesis
marine drug
pyrrolidinedione
secondary metabolites
cancer preventive
chemopreventive
trabectedin
plitidepsin
tumor-associated macrophages
tumor microenvironment
preclinical
anticancer immunity
antiangiogenesis
fascaplysin
cyclin-dependent kinase
small cell lung cancer
camptothecin
poly(ADP-ribose)-polymerase inhibitor
breast cancer
seaweed
therapeutic compounds
autophagy
marine drugs
autophagy inhibitors
autophagy inducers
macrolide
programmed cell death
energy stress
araguspongine C
c-Met
HER2
gemcitabine
pazopanib
phase I
safety
soft tissue sarcoma
pachastrissamine
jaspine B
carbocyclic analogue
sphingosine kinase inhibitor
molecular modeling
ET-743
DNA minor groove binder
soft tissue sarcoma
chemotherapy
bis (2,3-dibromo-4,5-dihydroxy-phenyl)-methane (BDDPM)
anti-metastatic activity
cell adhesion
β1-integrin
FAK
BEL-7402 cell
triterpene glycosides
sea cucumbers
antitumor activities
arrest of cell cycle
antibacterial
marangucyclines
deep-sea
Streptomyces sp. SCSIO 11594
LS-1
SNU-C5/5-FU
TGF-β signaling
carcinoembryonic antigen
kalkitoxin
Moorea producens
mitochondria toxin
VEGF
angiogenesis inhibitor
hypoxia-inducible factor-1
HIF-1
Lyngbya majuscula
marine metabolites
SZ-685C
nonfunctioning pituitary adenomas
Ecklonia cava
phlorotannins
dieckol
migration
sipholenol A
ABC transporter
multidrug resistance
P-gp/ABCB1
BCRP/ABCG2
MRP1/ABCC1
marine natural products
glioblastoma
xyloketal B
proliferation
TRPM7
marine compound
ribosomal protein genes
snoRNA
FAU
RPS30
SNORA62
evolution
Porifera
Penicillium brevicompactum
Brevianamide
Mycochromenic acid derivative
antifouling
Caribbean sponge
plakortide
endoperoxide
leukemia
multi-drug resistant leukemia
Sarcophyton ehrenbergi
soft coral
terpenes
cembranoids
cytotoxic activity
molecular docking
uveal melanoma
oxidative stress
virtual screening
Topo I inhibitor
low toxic
natural product
Ulva fasciata
selenium-containing polysaccharide-protein complex
pseudopterosin
NF-κB
p65
inflammation
cytokine release
IL-6
TNFα
MCP-1
glucocorticoid receptor
paulomycins
Micromonospora
antitumor
Cantabrian Sea-derived actinobacteria
puupehenones
sponges
antiangiogenic
antitumoral
porifera/sponge
cancer genes
molecular oncology
bromophenol
molecular mechanisms
cell cycle
PI3K/Akt
p38/ERK
ROS
human lung cancer
glycosaminoglycans
antiproliferative
heparan sulphate
gliotoxin
NSCLC
adriamycin resistance
Sepia ink polysaccharides
antitumour
chemosensitization
anticoagulation
sea anemone
drug discovery
endothelial cells
RGD motif
kunitz type inhibitor
prostate cancer
antioxidant
natural marine compounds
marine biotechnology
microalgae
marine sponges
Aeroplysinin
Isofistularin
pheochromocytoma and paraganglioma
metastasis
cancer progression
cell adhesion molecules
integrin β1
hypoxia
phycocyanin
non-small cell lung cancer
NF-κB signaling
marine-derived drugs
bioanalysis
chromatography
manzamine A
epithelial-mesenchymal transition
lung cancer
circulating tumor cells
signal transduction
cisplatin
Lampetra morii
buccal gland
cystatin F
anti-angiogenesis
cystatin superfamily
Antimicrobial peptide (AMP)
Tilapia piscidin 4 (TP4)
non-small cell lung cancer (NSCLC)
itampolin A
FBDD
p38α
novel inhibitor
tetracenomycin X
cyclin D1
proteasomal degradation
p38
c-JUN
λ-carrageenan
heparanase
anticoagulant
depolymerisation
cell migration
Aspergillus
naphthopyrones
endophytic fungus
Leathesia nana
mangrove-derived actinomycete
ansamycins
divergolides
apoptosis-inducing activity
actinomycin
EMT
invasion
low molecular weight fucoidan extract
N-Ras
neuroblastoma-rat sarcoma
Cancer
programmed cell death-ligand 1
programmed cell death-ligand 2
human sarcoma cell line (HT1080 cells)
human normal diploid fibroblast (TIG-1 cells)
chimera
chemical conjugation
anticancer agent
hybridization
α9-nicotinic acetylcholine receptors (nAChRs)
breast cancer cells
αO-conotoxin GeXIVA
targeted therapy
gorgonian
Leptogorgia
humulane sesquiterpenoids
anticancer activity
12-deacetyl-12-epi-scalaradial
HeLa cells
Nur77
MAPK/ERK pathway
Mycalin A
C15 acetogenins
synthetic analogues
antiproliferative activity
A375 and HeLa cell lines
polyoxygenated steroids
sponge
Haliclona gracilis
Thalassia testudinum
thalassiolin B
polyphenols
CYP1A1
benzo[a]pyrene
JNK1/2
natural products
synergism
A549 cells
cytoskeleton
P2X7 receptor
pollution
anti-angiogenic
gene expression
HSP90
inhibitor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557339303321
Honecker Friedemann  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Method Development and Applications for Reduced-Risk Products in Separation Science
Method Development and Applications for Reduced-Risk Products in Separation Science
Autore Aldeek Fadi
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (154 p.)
Soggetto topico Research & information: general
Chemistry
Analytical chemistry
Soggetto non controllato on!® nicotine pouches
nicotine
dissolution
release profile
validation
product assessment
smokeless tobacco product
nicotine degradants
nicotine-related impurities
alkaloids
nicotine degradation products
nicotine pouches
reduced-risk products
constituents
method development
method validation
JUUL
aerosol
non-targeted analysis
chemical characterization
ENDS
e-cigarette
GC-MS
LC-HRMS
e-liquid
2,4-DNPH derivatization
formaldehyde
"hidden formaldehyde"
formaldehyde-containing hemiacetal/acetal adducts
HPHC
3-hydroxybenzo[a]pyrene
LC-MS/MS
urine
human biomonitoring
derivatization
potentially reduced-risk products
propylene glycol
electronic cigarette
biomarker of exposure
compliance marker
oral tobacco derived nicotine (OTDN) pouches
snus
nicotine release
nicotine dissolution
nicotine extraction
equivalence
modern oral nicotine products
HPHCs
product characterizations
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566466903321
Aldeek Fadi  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2
Autore Luparello Claudio
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (318 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato berberine
signaling pathways
oncogenic cascades
TRAIL
microRNAs
cancer therapy
colon cancer cells
ethanol
Nrf2
HO-1
ER stress
autophagy
MMPs
formononetin
cancer
preclinical models
cell signaling
angiogenesis
nobiletin
colorectal cancer
chemoprevention
bioactivities
experimental therapeutics
HDAC
multiple myeloma
oleacein
breast cancer
persistent organic pollutants
breast cancer risk
breast cancer prognostic
systematic review
carrageenan
invasion
metastasis
RacGAP1
radiotherapy
marine sponge
natural product
anticancer drug
oral cancer inhibition
phytochemicals
small organic agents
Piper eriopodon, alkenylphenols
human cancer cells
cell death
apoptosis
caspase-independent cell death
XIAP antagonists
XIAP-BIR3 domain
Calocedrus formosana
lung cancer
yatein
cell-cycle arrest
xenograft
isorhamnetin
G2/M arrest
ROS
AMPK
pancreatic cancer
epigallocatechin-3-gallate (EGCG)
gemcitabine
glycolysis
phosphofructokinase
natural polyphenols
anticancer activities
molecular mechanisms
Streptomyces
mangrove
anti-proliferative
colon cancer
epithelial mesenchymal transition
inflammation
malignant cancer
natural anti-inflammatory compounds
pro-resolving lipids
anticancer drugs
flavonoids
natural compounds
Xenopus laevis
AOM/DSS model
melanoma cells
nicotine
α9-nAChR
PD-L1
STAT3
gigantol
AKT
JAK/STAT
cancer stem cell
tumor maintenance
tumor density
proteomics
honokiol
anticancer
mechanism
signalling pathway
uterine sarcoma
fucoidan
isobolography
colchicine alkaloid
mesoporous silica nanoparticles
targeted delivery system
PD-1 immune checkpoint inhibitor and cancer immunotherapy
glucose transport
drugs
innate immunity
β-glucans
nutrition
immunotherapy
estrogen
estrogen receptor alpha
polyphenols
daidzein
daidzein metabolites
paclitaxel
breast cancer cells
obesity
renin-angiotensin system
eicosapentaenoic acid
adipocyte inflammation
olive leaf extract
oleuropein
Seahorse analysis
cancer metabolism
glycolytic markers
Malva pseudolavatera Webb &
Berthel
acute myeloid leukemia
reactive oxygen species
brain cancer
gliomas
schwannomas
malignant tumors of the peripheral nerve sheath (MPNST)
neurofibromas
bioavailability
nanoparticle-based delivery systems
natural bioactive compound
gallic acid
EGFR signaling
p53
EGCG
non-coding RNAs
anti-cancer drug
NSCLC
EGFR TKI
FASN inhibitors
resistance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Role of Natural Bioactive Compounds in the Rise and Fall of Cancers
Record Nr. UNINA-9910557476303321
Luparello Claudio  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Sex, Gender and Substance Use
Sex, Gender and Substance Use
Autore Greaves Lorraine
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (272 p.)
Soggetto topico Humanities
Social interaction
Soggetto non controllato alcohol
pregnancy
abortion
policy
gender
substance use
FASD prevention
program evaluation
multi-service program delivery
client perspectives
interpersonal violence
domestic violence
intervention
women
developmental–relational
gender-specific approach
non-medical prescription opioid use
sleep disturbance
sex differences
adolescents
sexual minorities
illegal substance use
homophobic bullying
alcohol’s harms to others
gender equality
drinking cultures
developmental-relational
electronic cigarettes
cigarettes
waterpipe
hookah
polytobacco use
young adults
sex
cognitions
attitudes
scoping review
barriers
facilitators
fathers
males
smoking
smoke-free home
second-hand smoke
brief intervention
college campus
gender transformative
gender equity
cannabis
sex- and gender-based analysis
SGBA
cannabis use disorder
randomized controlled trial
gender norms
gender roles
gender relations
technology
health promotion
SGBA+
substance use prevention
tobacco
smoking cessation
clinical decision support systems
prevention
alcohol consumption
FASD
lifestyle
public health
Spain
sex factors
substance abuse
drinking
nicotine
research
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557799003321
Greaves Lorraine  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Autore Stefanachi Angela
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (416 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato EGR-1
flavonoid
(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile
MDA-MB-231
MMP9
TNFα
pancreatic ductal adenocarcinoma
cyclodextrin inclusion complex
phase solubility studies
preformulation studies
biphenylnicotinamide derivatives
dual inhibitor
EGFR
VEGFR2
ligand-based pharmacophore
molecular docking
molecular dynamics
leukemias
doxorubicin
inflammation
drug delivery
tumor targeting
elastin-like polypeptide
cell penetrating peptide
matrix metalloproteinase
doxorubicin resistance
photosensitizer delivery system
PAMAM dendrimer
photodynamic therapy
cytotoxicity
phototoxicity
colorectal adenocarcinoma
dicarboximides
chemical synthesis
apoptosis
kinases
anticancer
gene profiling
SAR
biomarkers
colorectal cancer
early detection examination
liquid biopsy
personalized medicine
tumor treatment
exosomes
ctDNA
CTC
cytotoxic activity
pyrazole derivatives
MTT assay
ADMET analysis
single-crystal diffraction
FTIR spectroscopy
NMR spectroscopy thermogravimetric analysis
acute myelogenous leukemia
platelets
microparticles
γδ T cells
immunotherapy
tumor resistance
combination therapy
tumor microenvironment
immune checkpoint inhibitor
neuroblastoma
molecular iodine
cyclophosphamide
xenografts
metronomic therapy
tamoxifen
CYP2D6
MCF-7
Ishikawa cells
SERM
TNBC
uterotrophic
α-mangostin
poly(amidoamine) dendrimer
targeted drug delivery
biotin targeting
glioblastoma multiforme
squamous cell carcinoma
antiparasitic therapy
diclofenac
indomethacin
oleanolic acid derivative conjugates
NF-κB
Nrf2
MAPKs
PSN-1 cells
reactive oxygen species
glioblastoma
brain tumor
extracellular vesicles
pancreatic cancer
paclitaxel
clathrin
endocytosis
sulforaphane
nicotine
metalloproteinase-9
gastric cancer
cell invasion
Arylquin 1
colon cancer
tumor progression
azelastine
oxidative stress
autophagy
mitotic catastrophe
chronic myeloid leukemia
imatinib
tyrosine kinase
ketoconazole
P-glycoprotein
drug efflux transporter
non-small-cell lung cancer
cisplatin resistance
aldehyde dehydrogenase
isothiocyanates
disulfiram
epithelial to mesenchymal transition
aminopeptidase N
acetamidophenones
Schiff bases
semicarbazones
thiosemicarbazones
inhibition of proliferation
ISBN 3-0365-5927-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639990003321
Stefanachi Angela  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Clinical Utility of Food Addiction and Eating Addiction
The Clinical Utility of Food Addiction and Eating Addiction
Autore Cassin Stephanie
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (246 p.)
Soggetto topico Medicine
Surgery
Soggetto non controllato overweight
obesity
food addiction
eating addiction
food intake variety
eating behavior
overeating
addictive eating
health professional
clinician
bariatric surgery
Yale Food Addiction Scale
cognitive behavioural therapy
telephone therapy
eating disorder
dietary restraint
substance use disorder
posttraumatic stress disorder
trauma
adverse childhood experience
early life adversity
psychiatric comorbidity
clinical vignette
clinical utility
psychosocial impairment
comorbidity
quality of life
processed food
nutrition
non-communicable disease
metabolic syndrome
diabetes
addiction
policy
stress
dopamine
epigenetics
biopsychosocial
weight loss
treatment
food
nicotine
tobacco use disorder
food intake
eating behaviour
diet
overconsumption
binge eating
weight gain
hedonic pathway
homeostatic pathway
binge-eating disorder
weighing
eating disorders
addictive behaviors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557450203321
Cassin Stephanie  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Role of PPARs in Disease
The Role of PPARs in Disease
Autore Wagner Nicole
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (274 p.)
Soggetto topico Medicine
Physiology
Soggetto non controllato peroxisome-proliferator activated receptors
tumor angiogenesis
tumor progression
metastasis formation
endothelial cells
RNA sequencing
PPARs
toxicology
pharmacology
ligand
vascular
coronary artery
lipidomics
eicosanoids
inflammation
CYP450
peroxisome proliferator-activated receptor
angiogenesis
proliferation
metastasis
immortality
resistance to cell death
growth suppressors
immune system
cellular metabolism
PPAR
nuclear receptors
addiction
alcohol
nicotine
opioids
psychostimulants
animal models
human studies
Alzheimer’s
risk factors
PPARα
lipids
fatty acids
modulators
cognition
sex
therapy
hypertrophic adipocytes
PPARG isoforms
PPARG splicing
dominant-negative isoform
in vitro adipocytes
adipogenesis
hypertrophic obesity
insulin-resistance
peroxisome proliferator-activated receptors (PPARs)
synthetic agonists
non-alcoholic fatty liver disease (NAFLD)
non-alcoholic steatohepatitis (NASH)
fibrosis
Sirtuin1
peroxisome proliferator-activated receptor-γ coactivator-1α
peroxisome proliferator activated receptors
obesity
metabolic syndrome
vitamin B12
folate
fetal programming
inherited metabolic disorders
PGC-1α, disease
kidney
cancer
AKI
CKD
nephron
PKD
cilia
cystogenesis
ligands
Alzheimer’s disease (AD)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566482503321
Wagner Nicole  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui